Transient global amnesia

Summary

Transient global amnesia (MONDO:0001617) is a disease and 5 clinical trials. A subtype of amnestic disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 5

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	transient global amnesia
Mondo ID	MONDO:0001617
MeSH	D020236
DOID	DOID:13027
ICD-10-CM	G45.4
ICD-11	1524600518
NCIT	C85198
UMLS	C0338591
MedGen	83275
GARD	0027583
Is cancer (heuristic)	no

Also known as: transient global amnesia · transient global amnesia (disease)

Data availability: 1 HPO phenotype.

Disease family

This is a subtype of amnestic disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by developmental or physiological process › psychiatric disorder › cognitive disorder › amnestic disorder › transient global amnesia

Related subtypes (3): retrograde amnesia, anterograde amnesia, alcohol amnestic disorder

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 5.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	5

Top trials by phase / activity

NCT	Phase	Status	Title
NCT01793168	Not specified	RECRUITING	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
NCT06903026	Not specified	RECRUITING	PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome
NCT07009990	Not specified	NOT_YET_RECRUITING	Coronary and Cerebral Microvascular Dysfunction in Neurological Diseases
NCT02562560	Not specified	TERMINATED	Neuropsycholgy and Neuroimaging in Transient Global Amnesia
NCT03739008	Not specified	COMPLETED	Reversible Cerebral Vasoconstriction Syndrome With Concomitant Transient Global Amnesia